Ryan Tunis
Stock Analyst at Cantor Fitzgerald
(3.20)
# 2,280
Out of 5,182 analysts
58
Total ratings
56%
Success rate
1.71%
Average return
Main Sectors:
Stocks Rated by Ryan Tunis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CB Chubb | Reiterates: Neutral | $315 | $324.60 | -2.96% | 2 | Apr 22, 2026 | |
| WTW Willis Towers Watson | Maintains: Neutral | $363 → $354 | $289.34 | +22.35% | 2 | Apr 9, 2026 | |
| WRB W. R. Berkley | Downgrades: Neutral | $75 → $71 | $66.20 | +7.25% | 3 | Apr 9, 2026 | |
| TRUP Trupanion | Maintains: Neutral | $42 → $34 | $27.25 | +24.77% | 2 | Apr 9, 2026 | |
| RYAN Ryan Specialty Holdings | Maintains: Neutral | $45 → $40 | $34.74 | +15.14% | 3 | Apr 9, 2026 | |
| RNR RenaissanceRe Holdings | Upgrades: Overweight | $306 → $340 | $310.99 | +9.33% | 2 | Apr 9, 2026 | |
| KNSL Kinsale Capital Group | Maintains: Neutral | $360 → $280 | $327.75 | -14.57% | 3 | Apr 9, 2026 | |
| HIG The Hartford Insurance Group | Maintains: Overweight | $165 → $160 | $136.71 | +17.04% | 8 | Apr 9, 2026 | |
| GSHD Goosehead Insurance | Maintains: Overweight | $84 → $67 | $48.25 | +38.86% | 2 | Apr 9, 2026 | |
| AIG American International Group | Maintains: Neutral | $77 → $81 | $74.13 | +9.27% | 6 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $97 → $100 | $96.35 | +3.79% | 2 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $220 | $214.20 | +2.71% | 4 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $316 → $319 | $303.74 | +5.02% | 5 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $208 → $212 | $170.15 | +24.60% | 1 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $393 → $412 | $323.78 | +27.25% | 2 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $92 | $65.60 | +40.24% | 1 | Jan 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $348 → $344 | $343.52 | +0.14% | 1 | Jan 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $344 → $282 | $215.06 | +31.13% | 3 | Jan 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $201.98 | -57.92% | 6 | Oct 18, 2019 |
Chubb
Apr 22, 2026
Reiterates: Neutral
Price Target: $315
Current: $324.60
Upside: -2.96%
Willis Towers Watson
Apr 9, 2026
Maintains: Neutral
Price Target: $363 → $354
Current: $289.34
Upside: +22.35%
W. R. Berkley
Apr 9, 2026
Downgrades: Neutral
Price Target: $75 → $71
Current: $66.20
Upside: +7.25%
Trupanion
Apr 9, 2026
Maintains: Neutral
Price Target: $42 → $34
Current: $27.25
Upside: +24.77%
Ryan Specialty Holdings
Apr 9, 2026
Maintains: Neutral
Price Target: $45 → $40
Current: $34.74
Upside: +15.14%
RenaissanceRe Holdings
Apr 9, 2026
Upgrades: Overweight
Price Target: $306 → $340
Current: $310.99
Upside: +9.33%
Kinsale Capital Group
Apr 9, 2026
Maintains: Neutral
Price Target: $360 → $280
Current: $327.75
Upside: -14.57%
The Hartford Insurance Group
Apr 9, 2026
Maintains: Overweight
Price Target: $165 → $160
Current: $136.71
Upside: +17.04%
Goosehead Insurance
Apr 9, 2026
Maintains: Overweight
Price Target: $84 → $67
Current: $48.25
Upside: +38.86%
American International Group
Feb 17, 2026
Maintains: Neutral
Price Target: $77 → $81
Current: $74.13
Upside: +9.27%
Feb 17, 2026
Maintains: Neutral
Price Target: $97 → $100
Current: $96.35
Upside: +3.79%
Feb 5, 2026
Reiterates: Neutral
Price Target: $220
Current: $214.20
Upside: +2.71%
Feb 2, 2026
Maintains: Overweight
Price Target: $316 → $319
Current: $303.74
Upside: +5.02%
Feb 2, 2026
Maintains: Overweight
Price Target: $208 → $212
Current: $170.15
Upside: +24.60%
Feb 2, 2026
Maintains: Overweight
Price Target: $393 → $412
Current: $323.78
Upside: +27.25%
Jan 14, 2026
Maintains: Overweight
Price Target: $85 → $92
Current: $65.60
Upside: +40.24%
Jan 14, 2026
Maintains: Neutral
Price Target: $348 → $344
Current: $343.52
Upside: +0.14%
Jan 14, 2026
Downgrades: Neutral
Price Target: $344 → $282
Current: $215.06
Upside: +31.13%
Oct 18, 2019
Maintains: Outperform
Price Target: $90 → $85
Current: $201.98
Upside: -57.92%